Packaging - Tamper verification features for medicinal product packaging (ISO 21976:2018)

This document specifies requirements and provides guidance for the application, use and check of tamper verification features to the packaging of medicinal products.

Verpackung - Merkmale zur Überprüfung von Manipulationen an Arzneimittelverpackungen (ISO 21976:2018)

Dieses Dokument legt Anforderungen fest und enthält Anleitungen zur Anbringung, Verwendung und Prüfung von Merkmalen zur Überprüfung von Manipulationen an Arzneimittelverpackungen.
Die in dem vorliegenden Dokument enthaltenen Grundsätze können entsprechend in anderen Bereichen angewendet werden.

Emballage - Témoins d'effraction pour emballages de médicaments (ISO 21976:2018)

Le présent document définit les exigences et fournit des recommandations pour l'application, l'utilisation et le contrôle des témoins d'effraction sur les emballages de médicaments.
Les principes du présent document peuvent être appliqués dans d'autres secteurs, selon le cas.

Embalaža - Značilnosti preverjanja nedovoljenega poseganja v embalažo za zdravila (ISO 21976:2018)

General Information

Status
Published
Publication Date
13-Oct-2020
Withdrawal Date
29-Apr-2021
Technical Committee
CEN/TC 261 - Packaging
Current Stage
6060 - Definitive text made available (DAV) - Publishing
Start Date
14-Oct-2020
Due Date
28-May-2022
Completion Date
14-Oct-2020

Relations

Effective Date
08-Jun-2022

Overview

EN ISO 21976:2020 (identical to ISO 21976:2018) is a CEN-adopted standard that specifies requirements and provides guidance for the application, use and check of tamper verification features for medicinal product packaging. It harmonizes industry practice across Europe and internationally to reduce risk from unauthorized opening or manipulation and to support patient safety and regulatory compliance.

Key topics and technical scope

This standard covers descriptions, functional criteria and verification guidance for a range of tamper verification solutions used on medicinal packaging. Key topics include:

  • General requirements: purpose, selection and application of tamper verification features and guidance on how they are intended to be used and checked.
  • Categories of features: organized guidance for common packaging formats such as:
    • folding boxes (including glue-closed and specially constructed boxes)
    • sealing labels and tapes
    • film wrappers and sleeves
    • breakable or tear-away closures
    • container inner seals or membranes
    • display blister packs and flexible packaging
    • blow-fill-and-seal (BFS) containers
    • new and emerging technologies
  • For each category: a description, criteria of tamper verification and verification approaches (inspection/check procedures).
  • Informative annexes: additional background information and bibliography to support implementation.

Practical applications and users

EN ISO 21976:2020 is practical for professionals who design, produce, inspect or regulate medicinal packaging:

  • Pharmaceutical manufacturers choosing or specifying tamper verification solutions to meet safety and regulatory expectations.
  • Packaging designers and converters developing cartons, seals, blisters, sleeves and tamper labels.
  • Contract packagers and CMOs implementing compliant closure and inspection processes.
  • Quality assurance and regulatory affairs teams validating packaging integrity and documenting compliance.
  • Regulators and inspection bodies seeking a harmonized basis for assessing tamper-verification measures.
  • Procurement and supply chain managers evaluating suppliers and materials for tamper-evident performance.

Use cases include selecting an appropriate tamper verification feature for a product presentation, developing routine inspection procedures for release, and demonstrating alignment with regulatory frameworks.

Related standards and context

  • EN ISO 21976:2020 supersedes EN 16679:2014 and incorporates ISO 21976:2018 text.
  • The standard was developed by ISO/TC 122 (Packaging) and adopted by CEN/TC 261 (Packaging).
  • It supports regulatory aims such as those in Directive 2001/83/EC and Directive 2011/62/EU (Falsified Medicines Directive) by promoting harmonized tamper verification practices.

Keywords: tamper verification, tamper-evident, medicinal product packaging, EN ISO 21976:2020, ISO 21976, pharmaceutical packaging standards, tamper verification features.

Frequently Asked Questions

EN ISO 21976:2020 is a standard published by the European Committee for Standardization (CEN). Its full title is "Packaging - Tamper verification features for medicinal product packaging (ISO 21976:2018)". This standard covers: This document specifies requirements and provides guidance for the application, use and check of tamper verification features to the packaging of medicinal products.

This document specifies requirements and provides guidance for the application, use and check of tamper verification features to the packaging of medicinal products.

EN ISO 21976:2020 is classified under the following ICS (International Classification for Standards) categories: 11.120.99 - Other standards related to pharmaceutics; 55.020 - Packaging and distribution of goods in general. The ICS classification helps identify the subject area and facilitates finding related standards.

EN ISO 21976:2020 has the following relationships with other standards: It is inter standard links to EN 16679:2014. Understanding these relationships helps ensure you are using the most current and applicable version of the standard.

You can purchase EN ISO 21976:2020 directly from iTeh Standards. The document is available in PDF format and is delivered instantly after payment. Add the standard to your cart and complete the secure checkout process. iTeh Standards is an authorized distributor of CEN standards.

Standards Content (Sample)


SLOVENSKI STANDARD
01-december-2020
Nadomešča:
SIST EN 16679:2015
Embalaža - Značilnosti preverjanja nedovoljenega poseganja v embalažo za
zdravila (ISO 21976:2018)
Packaging - Tamper verification features for medicinal product packaging (ISO
21976:2018)
Verpackung - Merkmale zur Überprüfung von Manipulationen an
Arzneimittelverpackungen (ISO 21976:2018)
Emballage - Témoins d'effraction pour emballages de médicaments (ISO 21976:2018)
Ta slovenski standard je istoveten z: EN ISO 21976:2020
ICS:
11.120.99 Drugi standardi v zvezi s Other standards related to
farmacijo pharmaceutics
55.020 Pakiranje in distribucija blaga Packaging and distribution of
na splošno goods in general
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.

EN ISO 21976
EUROPEAN STANDARD
NORME EUROPÉENNE
October 2020
EUROPÄISCHE NORM
ICS 11.120.99; 55.020 Supersedes EN 16679:2014
English Version
Packaging - Tamper verification features for medicinal
product packaging (ISO 21976:2018)
Emballage - Témoins d'effraction pour emballages de Verpackung - Merkmale zur Überprüfung von
médicaments (ISO 21976:2018) Manipulationen an Arzneimittelverpackungen (ISO
21976:2018)
This European Standard was approved by CEN on 28 September 2020.

CEN members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for giving this
European Standard the status of a national standard without any alteration. Up-to-date lists and bibliographical references
concerning such national standards may be obtained on application to the CEN-CENELEC Management Centre or to any CEN
member.
This European Standard exists in three official versions (English, French, German). A version in any other language made by
translation under the responsibility of a CEN member into its own language and notified to the CEN-CENELEC Management
Centre has the same status as the official versions.

CEN members are the national standards bodies of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia,
Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway,
Poland, Portugal, Republic of North Macedonia, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and
United Kingdom.
EUROPEAN COMMITTEE FOR STANDARDIZATION
COMITÉ EUROPÉEN DE NORMALISATION

EUROPÄISCHES KOMITEE FÜR NORMUNG

CEN-CENELEC Management Centre: Rue de la Science 23, B-1040 Brussels
© 2020 CEN All rights of exploitation in any form and by any means reserved Ref. No. EN ISO 21976:2020 E
worldwide for CEN national Members.

Contents Page
European foreword . 3

European foreword
The text of ISO 21976:2018 has been prepared by Technical Committee ISO/TC 122 "Packaging” of the
International Organization for Standardization (ISO) and has been taken over as EN ISO 21976:2020 by
Technical Committee CEN/TC 261 “Packaging” the secretariat of which is held by AFNOR.
This European Standard shall be given the status of a national standard, either by publication of an
identical text or by endorsement, at the latest by April 2021, and conflicting national standards shall be
withdrawn at the latest by April 2021.
Attention is drawn to the possibility that some of the elements of this document may be the subject of
patent rights. CEN shall not be held responsible for identifying any or all such patent rights.
This document supersedes EN 16679:2014.
According to the CEN-CENELEC Internal Regulations, the national standards organizations of the
following countries are bound to implement this European Standard: Austria, Belgium, Bulgaria,
Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland,
Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Republic of
North Macedonia, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and the
United Kingdom.
Endorsement notice
The text of ISO 21976:2018 has been approved by CEN as EN ISO 21976:2020 without any modification.

INTERNATIONAL ISO
STANDARD 21976
First edition
2018-11
Packaging — Tamper verification
features for medicinal product
packaging
Emballage — Témoins d'effraction pour emballages de médicaments
Reference number
ISO 21976:2018(E)
©
ISO 2018
ISO 21976:2018(E)
© ISO 2018
All rights reserved. Unless otherwise specified, or required in the context of its implementation, no part of this publication may
be reproduced or utilized otherwise in any form or by any means, electronic or mechanical, including photocopying, or posting
on the internet or an intranet, without prior written permission. Permission can be requested from either ISO at the address
below or ISO’s member body in the country of the requester.
ISO copyright office
CP 401 • Ch. de Blandonnet 8
CH-1214 Vernier, Geneva
Phone: +41 22 749 01 11
Fax: +41 22 749 09 47
Email: copyright@iso.org
Website: www.iso.org
Published in Switzerland
ii © ISO 2018 – All rights reserved

ISO 21976:2018(E)
Contents  Page
Foreword .v
Introduction .vi
1  Scope . 1
2  Normative references . 1
3  Terms and definitions . 1
4  General requirements . 2
4.1 Tamper verification features . 2
4.2 Purpose of tamper verification features . 2
4.3 Application and use of tamper verification features . 2
4.4 Check of tamper verification features . 3
5  Categories of tamper verification features . 3
5.1 General . 3
5.2 Folding boxes closed with glue . 3
5.2.1 Description . . . 3
5.2.2 Criteria of tamper verification . 3
5.2.3 Verification . 3
5.3 Specially constructed folding boxes . 4
5.3.1 Description . . . 4
5.3.2 Criteria of tamper verification . 5
5.3.3 Verification . 5
5.4 Sealing labels and tapes . 5
5.4.1 Description . . . 5
5.4.2 Criteria of tamper verification . 6
5.4.3 Verification . 6
5.5 Film wrappers. 7
5.5.1 Description . . . 7
5.5.2 Criteria of tamper verification . 7
5.5.3 Verification . 7
5.6 Sleeves . 7
5.6.1 Description . . . 7
5.6.2 Criteria of tamper verification . 7
5.6.3 Verification . 7
5.7 Breakable or tear-away closure . 8
5.7.1 Description . . . 8
5.7.2 Criteria of tamper verification . 8
5.7.3 Verification . 8
5.8 Container inner seal or membrane . 9
5.8.1 Description . . . 9
5.8.2 Criteria of tamper verification . 9
5.8.3 Verification .10
5.9 Display blister pack .10
5.9.1 Description . . .10
5.9.2 Criteria of tamper verification .10
5.9.3 Verification .11
5.10 Flexible packaging .11
5.10.1 Description . . .11
5.10.2 Criteria of tamper verification .11
5.10.3 Verification .11
5.11 Blow-fill-and-seal-container (BFS) . .12
5.11.1 Description . . .12
5.11.2 Criteria of tamper verification .12
5.11.3 Verification .12
ISO 21976:2018(E)
5.12 New and emerging technologies .13
Annex A (informative) Additional information regarding tamper verification features .14
Bibliography .15
iv © ISO 2018 – All rights reserved

ISO 21976:2018(E)
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards
bodies (ISO member bodies). The work of preparing International Standards is normally carried out
through ISO technical committees. Each member body interested in a subject for which a technical
committee has been established has the right to be represented on that committee. International
organizations, governmental and non-governmental, in liaison with ISO, also take part in the work.
ISO collaborates closely with the International Electrotechnical Commission (IEC) on all matters of
electrotechnical standardization.
The procedures used to develop this document and those intended for its further maintenance are
described in the ISO/IEC Directives, Part 1. In particular, the different approval criteria needed for the
different types of ISO documents should be noted. This document was drafted in accordance with the
editorial rules of the ISO/IEC Directives, Part 2 (see www .iso .org/directives).
Attention is drawn to the possibility that some of the elements of this document may be the subject of
patent rights. ISO shall not be held responsible for identifying any or all such patent rights. Details of
any patent rights identified during the development of the document will be in the Introduction and/or
on the ISO list of patent declarations received (see www .iso .org/patents).
Any trade name used in this document is information given for the convenience of users and does not
constitute an endorsement.
For an explanation of the voluntary nature of standards, the meaning of ISO specific terms and
expressions related to conformity assessment, as well as information about ISO's adherence to the
World Trade Organization (WTO) principles in the Technical Barriers to Trade (TBT) see www .iso
.org/iso/foreword .html.
This document was prepared by Technical Committee ISO/TC 122, Packaging.
Any feedback or questions on this document should be directed to the user’s national standards body. A
complete listing of these bodies can be found at www .iso .org/members .html.
ISO 21976:2018(E)
Introduction
Requirements for tamper verification features on medicinal product packaging are emerging and
expanding globally to reduce risk and improve patient safety.
This document is to support the harmonization and implementation of tamper verification features to
the packaging of medicinal products worldwide.
The knowledge and experience gained in EN 16679:2014 has been used for developing this document.
The background for the creation of a European Standard for tamper verification features for medicinal
[6]
product packaging (EN 16679) was the European Directive 2001/83/EC , as amended by Directive
[7]
2011/62/EU , the latter commonly referred to as the “Falsified Medicines Directive” (FMD).
The packaging of medicinal products placed on the market and incorporating tamper verification
features in accordance with this document meets, as an example but not limited to, the requirements
[6] [7]
of Directive 2001/83/EC as amended by Directive 2011/62/EU . Article 54(o) of the Directive
stipulates, that on the outer packaging of certain medicinal products or, where there is no outer
packaging, on the immediate packaging must appear, among others, “a device allowing verification of
whether the outer packaging has been tampered with”.
vi © ISO 2018 – All rights reserved

INTERNATIONAL STANDARD ISO 21976:2018(E)
Packaging — Tamper verification features for medicinal
product packaging
1  Scope
This document specifies requirements and provides guidance for the application, use and check of
tamper verification features to the packaging of medicinal products.
The principles in this document can be applied in other sectors, as appropriate.
2  Normative references
There are no normative references in this document.
3  Terms and definitions
For the purposes of this document, the following terms and definitions apply.
ISO and IEC maintain terminological databases for use in standardization at the following addresses:
— ISO Online browsing platform: available at https: //www .iso .org/obp
— IEC Electropedia: available at http: //www .electropedia .org/
3.1
falsified medicinal product
medicinal products (3.6) that deliberately/fraudulently misrepresent their identity, composition or
source
[17]
[SOURCE: WHO, Definitions of Substandard and Falsified (SF) Medical Products, 2017 ]
3.2
finished product
authorized medicinal product (3.6) which has undergone all stages of production including packaging in
its final container as it is dispensed, sold or otherwise supplied
3.3
immediate packaging
primary packaging
container or other form of packaging directly in contact with the medicinal product (3.6)
3.4
manufacturing authorization holder
natural or legal person or entity that is authorized for total or partial manufacture
Note 1 to entry: This includes replacement of safety and tamper verification features (3.9) (in accordance with
[6] [7]
Directive 2001/83/EC , Article 47a(1)(b) as amended by Directive 2011/62/EU ).
3.5
market
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.

Loading comments...

The EN ISO 21976:2020 standard provides essential guidelines for the packaging of medicinal products, focusing on tamper verification features. Its scope is critically important as it specifies the requirements necessary for ensuring the integrity and safety of medicinal product packaging. This standard addresses the growing need for robust measures against tampering, which is vital for protecting public health and maintaining consumer trust. One of the strengths of EN ISO 21976:2020 is its comprehensive approach to the application, use, and verification of tamper-evident features in packaging. It includes detailed instructions that manufacturers can implement to enhance the security of their products, ensuring that any unauthorized access is easily detectable. This characteristic not only strengthens the packaging but also reinforces compliance with regulatory demands surrounding medicinal product safety. The relevance of this standard in today’s market cannot be understated. With the increasing incidence of counterfeit medications and concerns regarding product safety, EN ISO 21976:2020 positions itself as a key resource for pharmaceutical companies striving to meet safety regulations. Moreover, the guidance provided in the standard facilitates the development of packaging solutions that align with consumer expectations, thereby enhancing brand reputation and consumer confidence. In summary, the EN ISO 21976:2020 standard is a pivotal document for the medicinal product packaging industry. Its focus on tamper verification features is crucial for safeguarding public health while ensuring that manufacturers can effectively meet regulatory and consumer demands.

EN ISO 21976:2020은 의약품 포장에 대한 변조 확인 기능을 규정하는 중요한 표준으로, 의약품 안전성을 강화하는 데 필수적인 요소를 포함하고 있습니다. 이 문서는 변조 확인 기능의 적용, 사용 및 검증에 대한 요구 사항을 체계적으로 정리하고 있어, 의약품 포장에 종합적인 지침을 제공합니다. 이 표준의 강점 중 하나는 포장 디자인 단계에서부터 변조 확인 기능을 통합할 수 있도록 명확한 지침을 제시한다는 점입니다. 이를 통해 제조업체는 소비자에게 신뢰할 수 있는 제품을 제공할 수 있으며, 의약품의 품질과 안전성을 한층 향상시킬 수 있습니다. 또한, 변조 가능성이 있는 상황을 사전에 파악하고 대응할 수 있는 방안을 마련함으로써, 소비자의 안전을 최우선으로 고려하고 있습니다. EN ISO 21976:2020의 범위는 변조 확인 기능의 설치 및 사용할 수 있는 다양한 기술적 접근 방식을 포괄하여, 업계 전반에서 폭넓게 활용될 수 있는 유용한 자료로 자리잡고 있습니다. 이 표준은 의약품 포장 분야에서의 규제 요구 사항을 충족하고, 국제적인 기준에 부합하는 포장 솔루션을 제안함으로써 글로벌 시장에서도 긍정적인 영향을 미치고 있습니다. 결론적으로, EN ISO 21976:2020은 의약품 포장 분야의 품질 관리 및 변조 방지를 위한 필수 도구로, 관련 업계 종사자들에게 커다란 가치를 제공하며, 현대 의약품 안전성의 중요한 기준으로 작용하고 있음을 명확히 하고 있습니다.

SIST EN ISO 21976:2020は、医薬品パッケージのための改ざん確認機能に関する国際標準であり、その範囲は医薬品包装に関連する改ざん確認機能の要件を明確に定義し、それらの適用、使用、チェックに関する指針を提供しています。この標準は、医薬品の安全性と品質を確保するための重要な手段であり、業界全体における一貫した基準の確立に寄与しています。 この標準の強みは、具体的な要件と実用的なガイダンスを提供している点です。これにより、製造業者や流通業者は、改ざん確認機能の持つ重要性を理解し、実際の包装デザインにこれらの機能を効果的に組み込むことができます。また、この標準は法的な規制や市場のニーズにも適応されているため、業界の最新の動向に適した内容になっています。 さらに、EN ISO 21976:2020は、医薬品包装の盗難や偽造のリスクを軽減するために、改ざん防止機能の必要性を強調しており、消費者の信頼を守る役割も果たしています。このように、医薬品業界での適切なパッケージング手法を促進することで、患者の安全と健康を守るための重要な基盤を提供しています。 全体として、SIST EN ISO 21976:2020は、改ざん確認機能の実施に関する包括的な指針を示すことにより、医薬品のパッケージングにおける信頼性と安全性を高める役割を果たしています。この標準は、医薬品の包装に関与するすべての関係者にとって、必須のリファレンスとなるでしょう。

Die SIST EN ISO 21976:2020 ist ein grundlegendes Dokument, das wesentliche Anforderungen für die Implementierung und Überprüfung von Manipulationsprüfmerkmalen in der Verpackung von Arzneimitteln spezifiziert. Der Umfang dieser Norm befasst sich sowohl mit der Anwendung als auch der Nutzung dieser Merkmale, um die Integrität der Produktverpackung zu gewährleisten. Ein bedeutender Vorteil der Norm ist die klare Definition der Anforderungen, die sich darauf konzentriert, wie Manipulationsprüfmerkmale in der Praxis eingesetzt werden können. Dies fördert nicht nur die Sicherheit der Arzneimittelverpackungen, sondern schützt auch die Verbraucher vor potenziellen Gesundheitsrisiken durch gefälschte oder manipulierte Produkte. Die normativen Vorgaben sind so gestaltet, dass sie flexibel und anpassungsfähig an verschiedene Verpackungsarten und Marktbedürfnisse sind, wodurch die Relevanz der Norm in der schnelllebigen Pharmabranche verstärkt wird. Ein weiterer wichtiger Aspekt dieser Norm ist die fachliche Anleitung zur Überprüfung der entsprechenden Merkmale. Die Implementierung von Manipulationsprüfmerkmalen wird nicht nur als notwendige Sicherheitsmaßnahme betrachtet, sondern auch als ein strategisches Element zur Stärkung des Vertrauens in die Arzneimittelversorgung. Indem diese Norm die Anforderungen und Prüfmethoden systematisch behandelt, bietet sie Herstellern eine wertvolle Ressource zur Sicherstellung der Compliance mit den regulatorischen Anforderungen. Zusammenfassend lässt sich sagen, dass die SIST EN ISO 21976:2020 durch ihre umfassenden Vorgaben und die Fokussierung auf Sicherheit und Verbraucherschutz eine essentielle Grundlage für die Verpackung von Arzneimitteln darstellt. Die Norm hat sich als relevant und notwendig erwiesen, um den Herausforderungen der Verfälschungen im Arzneimittelmarkt wirksam zu begegnen.

La norme SIST EN ISO 21976:2020 traite des caractéristiques de vérification de l'empreinte d'usage pour l'emballage des produits médicaments. Elle spécifie les exigences essentielles et fournit des orientations précieuses pour l'application, l'utilisation et la vérification de ces fonctionnalités sur les emballages de médicaments. L'un des principaux atouts de cette norme réside dans son approche exhaustive, couvrant l'ensemble du processus, depuis la conception jusqu'à la mise en œuvre des dispositifs de vérification. Cela garantit non seulement la sécurité des produits pharmaceutiques mais renforce également la confiance des consommateurs face à la contrefaçon. Le champ d'application de la norme est particulièrement pertinent à une époque où la sécurité des médicaments est au premier plan des préoccupations de santé publique. Les dispositifs de vérification de non-usage contribuent de manière significative à minimiser les risques liés à l'intégrité des produits, ce qui en fait un référentiel indispensable pour les fabricants, les distributeurs et les autorités de régulation. En somme, la SIST EN ISO 21976:2020 est une norme vitale qui allie rigueur et pertinence, répondant aux besoins pressants d'une meilleure sécurité dans l'emballage des médicaments. Les recommandations qu'elle contient sont non seulement applicables, mais également adaptées aux évolutions technologiques et aux défis contemporains du secteur pharmaceutique, consolidant ainsi son rôle clé en matière de sécurité et de conformité.